Ben Richmond

Content by Ben Richmond


Researchers are unlocking the potential of stem cells to develop new ways of treating Parkinson’s disease, cancer and even injuries to the spinal cord.

Tom Okarma, CEO, president and director of Geron, a publicly traded technology company based in California, is starting the first phase of clinical trials for a human embryonic stem cell-based therapy to treat subacute thoracic spinal cord injuries. The first site for the trial is Northwestern Medicine.